Income tax expense · 2013–2025
Travere Therapeutics income tax expense
$988,000+723.3% · FY2025
Travere Therapeutics (TVTX) reported $988,000 in income tax expense for fiscal 2025, +723.3% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $988,000 | +723.3% | Open → |
| FY20242024-12-31 | $120,000 | −46.2% | Open → |
| FY20232023-12-31 | $223,000 | −28.8% | Open → |
| FY20222022-12-31 | $313,000 | −23.5% | Open → |
| FY20212021-12-31 | $409,000 | +$19.8M | Open → |
| FY20202020-12-31 | −$19.4M | −$19.3M | Open → |
| FY20192019-12-31 | −$21,000 | −$832,000 | Open → |
| FY20182018-12-31 | $811,000 | −40.7% | Open → |
| FY20172017-12-31 | $1.4M | +$11.0M | Open → |
| FY20162016-12-31 | −$9.7M | +$2.1M | Open → |
| FY20152015-12-31 | −$11.8M | −$9.3M | Open → |
| FY20142014-12-31 | −$2.5M | −$2.5M | Open → |
| FY20132013-12-31 | $76,000 | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +23.8%
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Travere Therapeutics income tax expense |url=https://companiesranked.com/en/company/travere-therapeutics/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Travere Therapeutics income tax expense. CompaniesRanked. https://companiesranked.com/en/company/travere-therapeutics/income-tax-expenseBibTeX
@misc{companiesranked-en-company-travere-therapeutics-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Travere Therapeutics income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/travere-therapeutics/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001438533-26-000014 · February 19, 2026
{{cite web |title=Travere Therapeutics income tax expense — 10-K (0001438533-26-000014) |url=https://www.sec.gov/Archives/edgar/data/1438533/000143853326000014/tvtx-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-19}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.